LLN

Trading Update: Lleida.net Demonstrates Steady Growth in Second Quarter of 2023 Driven by its Patented Technology

Retrieved on: 
Wednesday, July 19, 2023
Insurance, Intellectual property, Software as a service, Telecommunications, API, OTC Markets Group, Invention, EPA, BME, Dominican Republic, Acquisition, Patent, Growth, SMS, LLN, Mobile phone, EIDAS

MADRID, Spain, July 19, 2023 (GLOBE NEWSWIRE) -- Spanish listed company Lleida.net (BME:LLN) (EPA:ALLLN) (OTCQX:LLEIF) disclosed today its trading update for the second quarter of 2023, showcasing continued growth in the usage of its cutting-edge patented technology.

Key Points: 
  • MADRID, Spain, July 19, 2023 (GLOBE NEWSWIRE) -- Spanish listed company Lleida.net (BME:LLN) (EPA:ALLLN) (OTCQX:LLEIF) disclosed today its trading update for the second quarter of 2023, showcasing continued growth in the usage of its cutting-edge patented technology.
  • Active circuits for contract signings through API continue to show upward progression, with a 28.92% increase in June 2023 compared to June 2022.
  • The introduction of new features, such as electronic signatures, has significantly contributed to the rise in active circuits.
  • It subsequently executed a dual listing on Euronext Growth Paris in 2018 and on OTC Markets in New York in 2020.

Lleida.net obtains a new Indian patent for its method for certifying the sending of electronic email, and exceeds 300

Retrieved on: 
Monday, June 12, 2023
Intellectual property, Software as a service, Euronext Growth, Policy, BME Growth, EPA, BME, Patent, Coller, OTCQX, Growth, 301st, LLN, Mobile phone

India has 1,428 million inhabitants and a penetration of more than 1.25 billion cell phones, of which more than 850 million are smartphones.

Key Points: 
  • India has 1,428 million inhabitants and a penetration of more than 1.25 billion cell phones, of which more than 850 million are smartphones.
  • Valid until 2033, and under the title "METHOD FOR CERTIFYING THE SENDING OF ELECTRONIC MAIL", it has the potential to generate profits for the company of around 10 million euros over the next decade.
  • This milestone is a further sign of our continued expansion and growth in international markets," he added.
  • Lleida.net's growth strategy includes a strong intellectual property and R&D policy, as well as a reinforcement of its internationalization policy.

Lleida.net increases gross margin in the first quarter of 2023 and records an increase in its SaaS services

Retrieved on: 
Tuesday, May 9, 2023
Software as a service, Euronext Growth, International, BME Growth, EPA, BME, EBITDA, Wholesaling, OTCQX, Growth, Development, SMS, LLN, Video game, Mobile phone, Software

MADRID, Spain, May 09, 2023 (GLOBE NEWSWIRE) -- Technology services company Lleida.net (BME:LLN) (EPA:ALLLN) (OTCQX:LLEIF) increased its gross margin in the first quarter of 2023 by six percent over the same period last year, or EUR169,000.

Key Points: 
  • MADRID, Spain, May 09, 2023 (GLOBE NEWSWIRE) -- Technology services company Lleida.net (BME:LLN) (EPA:ALLLN) (OTCQX:LLEIF) increased its gross margin in the first quarter of 2023 by six percent over the same period last year, or EUR169,000.
  • In this first quarter, sales declined by 10 percent compared with the first quarter of 2022, closing at €4.69 million.
  • The Wholesale SMS market suffered a setback in the first quarter of 2023, with sales down 19 percent, while commercial SMS sales saw a decline in sales of 25 percent.
  • The natural decline in the SMS market has been replaced by growth in SaaS services.

Novartis presents new five-year data on disability outcomes and safety of Kesimpta® (ofatumumab) in people living with relapsing multiple sclerosis

Retrieved on: 
Thursday, April 20, 2023
Sequela, Sclerosis, Cleveland Clinic, Disability, AAN, Infection, Overalls, COVID-19, Aes, Immunoglobulin M, Urinary tract infection, American Academy, CDW, Multiple sclerosis, Barrow Neurological Institute, MS, RMS, Novartis, Patient, Risk, Common, Immunoglobulin G, Septic, American Academy of Neurology, Pneumonia, LLN, Safety, LGG, Disease, Pharmaceutical industry, MD, Ofatumumab

A separate analysis showed that treatment with Kesimpta for up to five years was well-tolerated, with no new or increased safety risks identified2.

Key Points: 
  • A separate analysis showed that treatment with Kesimpta for up to five years was well-tolerated, with no new or increased safety risks identified2.
  • These data will be presented at the American Academy of Neurology (AAN) Annual Meeting held in Boston and virtually on April 22-27, 2023.
  • Along with the five-year safety analysis, these data support this treatment as a well-tolerated, efficacious treatment option for people living with relapsing multiple sclerosis."
  • "Novartis remains committed to the multiple sclerosis community in our continued study of Kesimpta and to supporting those living with MS and their families throughout their journey."

Lleida.net, granted 72 new patents in Europe. Its digital signature solutions portfolio approaches 300 patents

Retrieved on: 
Tuesday, March 14, 2023
OTCQX, Research, Software as a service, BME, EIDAS, Adobe, BME Growth, DocuSign, Growth, LLN, EPA, Patent, Policy, Intellectual property, Euronext Growth, Fine chemical, Cryptocurrency

Patents received worldwide by the company now total 298 in what is one of the world's largest intellectual property portfolios in the field of trusted digital services.

Key Points: 
  • Patents received worldwide by the company now total 298 in what is one of the world's largest intellectual property portfolios in the field of trusted digital services.
  • The second patent, EP3767875, granted by the same countries, is for its "Method for signing contracts electronically."
  • "Our patented technologies are a testament to our commitment to innovation and excellence in the field of e-recruitment and digital signature solutions.
  • It can verify the veracity of any digital signature, regardless of the platform with which it was signed, be it Docusign, Adobe, qualified electronic signature or any other.

Lleida.net increases sales by 15% in 2022 and exceed 20 million euros, in its best earnings results to date

Retrieved on: 
Wednesday, March 8, 2023
Euronext Growth, Growth, LLN, OTCQX, Software as a service, EPA, Acquisition, BME, EBITDA, BME Growth, European, Airline

This more than €20 million represents a growth in sales of €2.7 million.

Key Points: 
  • This more than €20 million represents a growth in sales of €2.7 million.
  • International sales now account for 57% of the group's cumulative overall sales, focusing mainly on Europe and Latin America.
  • The investment in team growth resulted in an increase in personnel expenses of €1.95 million to €6.34 million.
  • Since the start of the year, the company has traded more than €11 million in shares, and the company's stock has already appreciated by 20 percent.

Lleida.net receives three new patents in Europe and reaches a total of 224 international recognitions

Retrieved on: 
Monday, March 6, 2023
EPA, Intellectual property, OTCQX, Euronext Growth, European, BME Growth, Policy, BME, Growth, LLN, Airline

These three new patents follow on from the one received in mid-February 2022 for its method for electronic contract signing.

Key Points: 
  • These three new patents follow on from the one received in mid-February 2022 for its method for electronic contract signing.
  • With these patents, the Spanish company, a European leader in the registered electronic signature, notification and contracting industry, has now obtained 224 international recognitions.
  • The authors of the patents are the CEO of the company, Sisco Sapena, and Carolina Solá, part of the technical team of Lleida.net.
  • "Obtaining these three patents in three important countries is a further demonstration of our commitment to innovation and the protection of our intellectual property.

Lleida.net launches USVC, a defense against forged or revoked electronic signatures

Retrieved on: 
Tuesday, February 14, 2023
Software as a service, Patent, ETSI, Adobe, EPA, DocuSign, TSL, EIDAS, LLN, Fraud, XML, Documentation, TSP, BME, Risk, CADES, PDF, European, Microsoft Excel, Typesetting, Risk management, Security printing

MADRID, Spain, Feb. 14, 2023 (GLOBE NEWSWIRE) -- The listed company Lleida.net (BME:LLN) (EPA:ALLLN) (OTCQX:LLEIF) has just launched USVC, the first universal validator of electronic signatures.

Key Points: 
  • MADRID, Spain, Feb. 14, 2023 (GLOBE NEWSWIRE) -- The listed company Lleida.net (BME:LLN) (EPA:ALLLN) (OTCQX:LLEIF) has just launched USVC, the first universal validator of electronic signatures.
  • It can verify the veracity of any digital signature, regardless of the platform with which it was signed, be it Docusign, Adobe, qualified electronic signature or any other.
  • According to Sapena, "Our USVC is an important step into the future of electronic signature validation technology.
  • In addition, it verifies the format of certain signed documents such as electronic invoices and validates documents signed with eIDAS.

Lleida.net, recognized for its social strength by the Spanish Institute of Analysts in its first ESG report

Retrieved on: 
Thursday, February 9, 2023
Policy, Growth, AAA, Queen Sofía Spanish Institute, Intellectual property, Lighthouse, EPA, OTCQX, Union, ESG, BME Growth, BME, Sustainable Development Commission, Euronext Growth, LLN, Social, News

MADRID, Spain, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Spanish listed company Lleida.net (BME:LLN) (EPA:ALLLN) (OTCQX:LLEIF) has received a "B" rating in the sustainability, social commitment and corporate governance (ESG) report prepared for it by the Spanish Institute of Analysts as part of the Lighthouse program.

Key Points: 
  • MADRID, Spain, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Spanish listed company Lleida.net (BME:LLN) (EPA:ALLLN) (OTCQX:LLEIF) has received a "B" rating in the sustainability, social commitment and corporate governance (ESG) report prepared for it by the Spanish Institute of Analysts as part of the Lighthouse program.
  • The rating recognizes the company's contribution to society with an AAA rating, and applauds its efforts in the area of social policies.
  • "The Social pillar is a clear strength of Lleida.net", the document says.
  • It is listed on the OTCQX index in New York, on Euronext Growth in Paris and on BME Growth in Madrid.

Lleida.net receives its fifth patent from South Korean government

Retrieved on: 
Tuesday, January 24, 2023
Growth, Intellectual property, EPA, OTCQX, EIDAS, Union, Patent, BME Growth, BME, Euronext Growth, LLN, Research, Fine chemical, Airline

MADRID, Spain, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Spanish technology services company Lleida.net (BME:LLN) (EPA:ALLLN) (OTCQX:LLEIF) has received its fifth patent from the South Korean government, this time for one of its methods for producing electronic contracts.

Key Points: 
  • MADRID, Spain, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Spanish technology services company Lleida.net (BME:LLN) (EPA:ALLLN) (OTCQX:LLEIF) has received its fifth patent from the South Korean government, this time for one of its methods for producing electronic contracts.
  • The patent, which is valid for 20 years, is the company's 219th worldwide, and represents the consolidation of its technology in the Asian country.
  • On December 12, the company announced the granting of another patent by the Seoul authorities for its EIDAS certified contracting method.
  • The company estimates that this recognition has the potential to directly and indirectly generate three million euros in revenue over the next two decades.